Spain extends AstraZeneca dose gap to 16 weeks

Spain extends AstraZeneca dose gap to 16 weeks

"Though Pfizer, Moderna, Johnson & Johnson, and other companies have developed safe and effective COVID-19 vaccines, the uncontrolled spread of coronavirus poses significant risks to global vaccination efforts: as the virus proliferates, it evolves-increasing the risk of a variant developing that renders vaccinations ineffective". This showed the vast majority were patients who became infected just before getting their vaccine, or too soon after for immunity to develop.

In contrast with the government's previous statement that AstraZeneca would be used to vaccinated people aged 60 and above, Khairy said the government would now follow the National Pharmaceutical Regulatory Agency's (NPRA) registration of the vaccine for those aged 18 and above for the new AstraZeneca vaccination booking system.

And the CEO also pointed to the situation in India, which is experiencing a devastating wave of COVID-19 infections, where AstraZeneca's vaccine makes up 90% of the shots available. Several countries have recommended that the shot be given only to older people because of the potential side effect.

Experts are studying how common these "vaccine breakthrough cases" are, according to the CDC, which says there have been more than 7,100 reported so far. The move expands on the Biden administration's March decision to share about 4 million doses of the vaccine with Mexico and Canada.

Oxygen Tank Blast, Fire Kill 82 in Hospital
Daily virus cases now average around 8000, the highest since Iraq began recording infection rates early past year . Iraq's Prime Minister Mustafa Al-Kadhimi fired several health officials; he attributed the fire to " negligence ".

THE government sent 1.5 million AstraZeneca vaccine doses across Spain.

Prof Semple said the analysis was created to give Sage "a very early signal on whether vaccines were working in the real world", adding: "The absolute numbers of people being admitted to hospital after 21 days of the first dose is tiny".

AstraZeneca has yet to apply for emergency use authorisation (EUA) in the U.S., but the company has been making tens of millions of doses in the United States in the expectation that it will apply for and receive EUA eventually. AstraZeneca in turn authorizes other companies to produce the shots around the world.

Related Articles